The plaque assay was first described for titration of bacterial inoculums and clonal isolation, and was later adapted for testing antibiotics susceptibility and to study virulence factors and ...

Pearl Diagnostics will receive $1 million to evaluate the potential of a prototype assay for early detection of pneumonia caused by Pseudomonas aeruginosa.

First described for rickettsiae, the plaque assay methods have been adapted to other intracellular bacterial pathogens. There is no single model, thus each assay should be refined depending on the ...